Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Carvedilol for the Prevention of the Progression of Esophageal Varices in Hepatitis B Related Cirrhotic Patients With Anti-Viral Therapy

NCT03736265 is registered in ClinicalTrials.gov with Beijing Friendship Hospital as lead sponsor.

NCT NCT03736265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03736265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Carvedilol for the Prevention of the Progression of Esophageal Varices in Hepatitis B Related Cirrhotic Patients With Anti-Viral Therapy
Lead sponsor
Beijing Friendship Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
October 9, 2017
Completion date
December 30, 2022
Enrollment
240 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, liver, portal hypertension